Literature DB >> 18600197

West Nile virus activity--United States, 2007.

.   

Abstract

West Nile virus (WNV) is the leading cause of arboviral encephalitis in the United States. Originally identified in Africa in 1937, WNV was first detected in the western hemisphere in 1999 in New York City. Since then, WNV has caused seasonal epidemics of febrile illness and neurologic disease in the United States. This report summarizes national WNV surveillance data for 2007. WNV transmission to humans or animals expanded into 19 counties that had not reported transmission previously and recurred in 1,148 counties where transmission had been reported in previous years. A total of 1,227 cases of WNV neuroinvasive disease (WNND) and 117 deaths were reported. These findings highlight the need for ongoing surveillance, mosquito control, promotion of personal protection from mosquito bites, and research into additional prevention strategies, including a WNV human vaccine.

Entities:  

Mesh:

Year:  2008        PMID: 18600197

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  8 in total

1.  Happy new fear: new disease of the year.

Authors:  Karmen Loncarek
Journal:  Croat Med J       Date:  2009-06       Impact factor: 1.351

2.  Epidemiology of West Nile virus in the highly epidemic state of North Dakota, 2002-2007.

Authors:  Stephanie M Borchardt; Michelle A Feist; Tracy Miller; Tze Shien Lo
Journal:  Public Health Rep       Date:  2010 Mar-Apr       Impact factor: 2.792

3.  The RIG-I-like receptor LGP2 controls CD8(+) T cell survival and fitness.

Authors:  Mehul S Suthar; Hilario J Ramos; Margaret M Brassil; Jason Netland; Craig P Chappell; Gabriele Blahnik; Aimee McMillan; Michael S Diamond; Edward A Clark; Michael J Bevan; Michael Gale
Journal:  Immunity       Date:  2012-07-26       Impact factor: 31.745

4.  IPS-1 is essential for the control of West Nile virus infection and immunity.

Authors:  Mehul S Suthar; Daphne Y Ma; Sunil Thomas; Jennifer M Lund; Nu Zhang; Stephane Daffis; Alexander Y Rudensky; Michael J Bevan; Edward A Clark; Murali-Krishna Kaja; Michael S Diamond; Michael Gale
Journal:  PLoS Pathog       Date:  2010-02-05       Impact factor: 6.823

5.  Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in mice.

Authors:  Matthew D Dunn; Shannan L Rossi; Donald M Carter; Matthew R Vogt; Erin Mehlhop; Michael S Diamond; Ted M Ross
Journal:  Virol J       Date:  2010-05-12       Impact factor: 4.099

6.  Toll-like receptor-3 is dispensable for the innate microRNA response to West Nile virus (WNV).

Authors:  Pauline E Chugh; Blossom A Damania; Dirk P Dittmer
Journal:  PLoS One       Date:  2014-08-15       Impact factor: 3.240

7.  HTS-driven discovery of new chemotypes with West Nile Virus inhibitory activity.

Authors:  Dong Hoon Chung; Colleen B Jonsson; Clinton Maddox; Sara N McKellip; Blake P Moore; Marintha Heil; E Lucile White; Subramaniam Ananthan; Qianjun Li; Shuang Feng; Lynn Rasmussen
Journal:  Molecules       Date:  2010-03-12       Impact factor: 4.411

8.  Successful treatment with intravenous immunoglobulin of acute flaccid paralysis caused by west nile virus.

Authors:  Mohammad Sami Walid; Fade Aziz Mahmoud
Journal:  Perm J       Date:  2009
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.